South Korea’s Constitutional Court opened the impeachment trial of President Yoon Suk Yeol on Tuesday, marking a pivotal moment in the nation’s political history following his controversial attempt to impose martial law.

The court’s first hearing was brief, adjourning shortly after it began at 2:00 pm (0500 GMT) due to Yoon’s absence.

A spokesperson confirmed the adjournment, stating the hearing lasted only minutes.

Yoon’s legal team cited “safety concerns” for his nonattendance, but the court plans to proceed with the remaining hearings as scheduled.

READ MORE: AGN President Responds To Reports Of Arrest In Umuahia

Yoon’s impeachment follows his December 3 directive for soldiers to storm parliament in an effort to block lawmakers from voting on his suspension of civilian rule.

The failed bid to impose martial law, South Korea’s first in over four decades, lasted just six hours and plunged the nation into its worst political crisis in decades.

The president was swiftly impeached and suspended from office. Since then, Yoon has remained at his residence, refusing summonses from investigators and relying on his presidential security team to resist arrest.

The Constitutional Court’s eight judges will assess whether Yoon’s declaration of martial law was unconstitutional or illegal—either of which would justify his removal.

A decision to uphold the impeachment requires six votes in favor.

The trial, which comprises five scheduled hearings, will continue Thursday, with additional sessions planned for January 21, January 23, and February 4. The court has until mid-June to deliver its ruling.

“This impeachment case focuses solely on the martial law situation,” said Kim Nam-ju, one of Yoon’s lawyers. “Since most of the individuals involved have already been indicted and the facts have been somewhat established, it doesn’t seem like it will take a long time.”

The National Assembly’s legal team has argued for swift action. “There are overwhelming reasons for the immediate dismissal of Yoon,” a representative said before the trial began Tuesday.

While the impeachment trial proceeds, a parallel criminal investigation into Yoon’s actions continues.

A joint team of investigators from the Corruption Investigation Office (CIO) and police is preparing another attempt to arrest the suspended president on insurrection charges.

A previous effort to detain Yoon was blocked by his security team, who have since fortified his residence with barbed wire, barricades, and increased patrols.

The defence ministry has clarified that nearby military units will not assist in any arrest attempts.

Yoon’s chief of staff, Chung Jin-suk, indicated a willingness to cooperate under specific conditions. “We are ready to consider all options for investigation or visits to the sitting leader at a third location,” he said.

If arrested, Yoon would become the first sitting South Korean president to face detention. A conviction on insurrection charges could result in life imprisonment or even the death penalty.

The impeachment trial comes as South Korea grapples with heightened political instability. Lawmakers also impeached Yoon’s stand-in last month, leaving the country’s leadership in disarray.

The acting president has called for dialogue and urged all parties to resolve the crisis peacefully.

“From the onset, there was a clear vision that this was going to be run not with the level of mediocrity that existed at the time, but it was going to be run as an international organization with the best practices.

So, there was excellence on-site from the get-go, and that was how the business was birthed,” said Kenneth Okolie, CEO of SYNLAB Nigeria.

These words encapsulate the bold aspirations that shaped the organization 20 years ago and continue to drive it today.

As SYNLAB celebrates its 20th anniversary, it reflects on two decades of reshaping healthcare diagnostics in Nigeria and the West African region.

Also Read >> Entrenching Trust In Medical Laboratories Through Service Quality, ISO 15189 Accreditation

From its early days as PathCare to its evolution into SYNLAB, the organization has consistently raised the bar in diagnostics care. PathCare, now SYNLAB, was the first ISO-accredited laboratory in West Africa, setting a new standard for healthcare quality and ethical practice.

This commitment to excellence has resulted in numerous firsts over the years, positioning SYNLAB as a leader in driving accessible and reliable healthcare services.

“We’ve been at the forefront of driving quality and accessible healthcare in this part of the world.

In Nigeria specifically, we have modelled what ethical practice in healthcare should be, collaborating with the government and public sector at different levels—federal, state, and local—to bring quality healthcare closer to the people,” Okolie remarked.

SYNLAB’s contributions to healthcare extend beyond Nigeria. By driving partnerships with pharmaceutical companies and the clinical research industry, SYNLAB has leveraged its expertise to advance science and localize tests that previously had to be sent abroad.

“We’ve done millions of tests and localized tons of diagnostics services that might not have been possible a couple of years ago,” Okolie noted, emphasizing SYNLAB’s impact on improving healthcare accessibility and affordability.

SYNLAB’s role in Nigeria’s healthcare ecosystem goes beyond diagnostics. Through collaborations with government and private institutions, the organization has been instrumental in advancing policies, infrastructure, and public health initiatives.

Also Read >> On SYNLAB Nigeria’s Secured Patient Portal, Test Result Delivery’s Safe Alternative

SYNLAB’s contributions to health education and advocacy have also been groundbreaking. It organizes quarterly webinars that educate the public on critical health issues and maintains a popular SYNLAB Podcast series, which features medical experts addressing pressing health topics.

These initiatives reflect SYNLAB’s commitment to empowering communities with knowledge and encouraging preventive healthcare.

Looking Ahead

“What would the next 20 years hold for SYNLAB? Well, 20 years is a lot to look out for, but I can say for a fact what we can look out for in the next 3–5 years,” said Okolie.

SYNLAB’s vision for the future includes:

• Becoming a more ambitious organization with increased investments in Nigeria.

• Driving quality healthcare even further and expanding partnerships with the government to improve access to care.

• Advocating universal basic healthcare and working closely with stakeholders to achieve this goal.

• Localizing even more tests to reduce dependency on external laboratories.

“SYNLAB looks forward to keeping pushing the envelope with regards to advancements in healthcare.

We are looking to become not just a household name in Nigeria but a leader in diagnostics within the West African space and, by extension, the sub-Saharan African region,” Okolie concluded.

A Celebration of Milestones

To mark this momentous occasion, SYNLAB Nigeria has lined up a series of activities, including free health screenings, and community outreach programs, discount sales and an anniversary dinner with relevant stakeholders.

These initiatives are a testament to SYNLAB’s gratitude to its patients, partners, and staff, who have made its 20-year journey a success.

As SYNLAB Nigeria celebrates this milestone, it reaffirms its commitment to delivering world-class diagnostics services, advancing healthcare innovation, and empowering Nigerians to live healthier lives.

About SYNLAB

• SYNLAB Nigeria is a member of the SYNLAB group, with presence in 35 countries in four continents. The organization has over 30 active locations across Nigeria and has been ISO 15189 certified since 2006.

• SYNLAB Group is the leader in medical diagnostic services and specialty testing in Europe. The Group offers a full range of innovative and reliable medical diagnostics to patients, practicing doctors, hospitals and clinics, governments and corporates.

• Providing the leading level of service within the industry, SYNLAB is the partner of choice for routine and specialty diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.

• SYNLAB holds leading positions in most markets, regularly reinforcing the strength of its network through a proven acquisition strategy.

• More information can be found on www.synlab.com, www.synlab.com.ng

The Senate and House of Representatives have resolved to exclude the Joint Admissions and Matriculation Board (JAMB) from the Federal Government’s 2025 budget, citing concerns over the agency’s financial practices and its dependence on public funds.

The decision was reached during an interactive session on revenue projections for 2025, held by the joint committee of the Senate and House of Representatives, chaired by Senator Sani Musa (APC, Niger East) on Monday.

READ MORE: Death Toll Rises As Wildfires Ravage Los Angeles

During the session, JAMB Registrar, Prof. Ishaq Oloyede, disclosed that the board had remitted N4 billion to the Consolidated Revenue Fund while receiving N6 billion from the government in 2024.

This revelation drew sharp criticism from lawmakers, who questioned the rationale behind funding a self-sustaining agency with government grants.

“You remitted N4 billion and received N6 billion from the Federal Government. Why not keep the N4 billion and stop the government from funding JAMB?” asked Abiodun Faleke, Chairman of the House Committee on Finance.

Senator Adams Oshiomhole (APC, Edo) expressed further concerns over JAMB’s spending patterns.

He pointed out that the agency spent N1.1 billion on meals and refreshments in 2024, a figure he described as excessive.

“Are you being freely fed by the government? This money comes from poor students, many of whom are orphans,” Oshiomhole said.

The senator also raised questions about N850 million allocated for security, cleaning, and fumigation, as well as N600 million spent on local travels.

Additionally, he called for a detailed explanation of N6.5 billion earmarked for local training and N1 billion allocated for a staff housing scheme.

Beyond JAMB, the Senate raised broader concerns about the financial practices of other Ministries, Departments, and Agencies (MDAs).

Senator Musa lamented the low remittances from MDAs in 2024 despite significant revenues generated, describing the gap as a major hindrance to funding critical infrastructure and social services.

“This discrepancy hampers the government’s ability to fund critical infrastructure projects and social services, raising issues of inefficiency, mismanagement, and potential revenue leakages,” Musa noted.